Related Experiment Video
Updated: Aug 15, 2026

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease
Published on: May 22, 2026
Relation of lower hematocrit to progression from asymptomatic left ventricular dysfunction to symptomatic heart
Sandeep R Das1, Daniel L Dries, Mark H Drazner
1Donald W. Reynolds Cardiovascular Clinical Research Center, Dallas, Texas, USA. sandeep.das@utsouthwestern.edu
Insights
Low hematocrit levels (< or = 40%) are linked to a higher risk of developing heart failure (HF) symptoms and hospitalization. This finding highlights hematocrit as a potential indicator for HF progression in patients with left ventricular systolic dysfunction.
Area of Science:
- Cardiology
- Hematology
Background:
- Left ventricular (LV) systolic dysfunction is a precursor to symptomatic heart failure (HF).
- The role of hematocrit in the progression of asymptomatic LV dysfunction to symptomatic HF requires further elucidation.
Purpose of the Study:
- To investigate the association between hematocrit levels and the risk of developing symptomatic heart failure (HF).
- To examine the relationship between hematocrit and adverse cardiovascular outcomes in patients with LV systolic dysfunction.
Main Methods:
- Analysis of data from 2,821 patients enrolled in the Studies of Left Ventricular Dysfunction Prevention trial.
- Stratification of patients into quartiles based on hematocrit levels.
- Utilizing survival analysis to determine hazard ratios (HR) and 95% confidence intervals (CI) for HF development and related events.
Main Results:
- Patients in the lowest hematocrit quartile (hematocrit <= 40%) demonstrated a significantly increased risk of developing HF symptoms (HR 1.79, 95% CI 1.37 to 2.34).
- Lower hematocrit was also associated with a higher risk of first HF hospitalization (HR 2.35, 95% CI 1.52 to 3.62).
- The risk of death or HF symptom development was elevated in the lowest hematocrit quartile (HR 1.60, 95% CI 1.28 to 1.99) compared to the highest quartile (hematocrit > 46%).
Conclusions:
- Hematocrit levels may serve as a prognostic marker for HF progression in patients with asymptomatic LV systolic dysfunction.
- Lower hematocrit is associated with an increased risk of adverse outcomes, including symptomatic HF and hospitalization.
- Further research is warranted to explore the underlying mechanisms and clinical implications of this association.
Abstract:
The relation between hematocrit and progression from asymptomatic left ventricular (LV) systolic dysfunction to symptomatic heart failure (HF) was examined in 2,821 patients from the Studies of Left Ventricular Dysfunction Prevention trial. Patients in the lowest hematocrit quartile (hematocrit < or = 40%) were at increased risk for the development of HF symptoms (hazard ratio [HR] 1.79, 95% confidence interval [CI] 1.37 to 2.34), first HF hospitalization (HR 2.35, 95% CI 1.52 to 3.62), and death or the development of HF symptoms (HR 1.60, 95% CI 1.28 to 1.99) compared with patients in the highest hematocrit quartile (hematocrit > 46%).
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure III: Clinical Manifestations
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care